Why Grail Shares Are Plummeting
Shares of cancer-detection firm Grail (NASDAQ: GRAL) fell by half in last Friday's trading session. That's quite a turnabout after the company's share price more than quintupled in 2025, from about $19 a share in January to $110 in November.
Last week shares of the California-based biotech were trading at around $102. Today they're priced at $49. What happened?
Image source: Getty Images.
Source Fool.com


